Answers are grounded in this paper and cite their sources.
Backbone thiazole (Thz) moieties prevail in bioactive peptidic natural products and play important roles in their biological functions. However, the de novo discovery of artificial Thz‐containing peptide ligands remains challenging. Here, we report an mRNA display‐based selection platform for Thz‐containing macrocyclic peptides ( Thz teMP), established through a dedicated posttranslational chemoenzymatic transformation. This method exploits the unique reactivity of ribosomally incorporated thioamides, enabling enzyme‐free spontaneous heterocyclization to form thiazoline (Thn), which is further oxidized using the substrate‐tolerant azoline dehydrogenase (GodE) to yield a Thz moiety. By integrating this chemoenzymatic process with chloroacetyl‐mediated thioether macrocyclization and mRNA display, we have successfully discovered Thz‐containing macrocyclic peptide ligands with high binding affinities against p21‐activated kinase 4 (PAK4). This study establishes a robust system to expedite ligand discovery of pseudo‐natural peptides and to investigate the functional benefit of their backbone Thzs.
No takes yet. Share an insight, caveat, or question.
Saito et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: